Literature DB >> 31772001

Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene.

David C LaFon1,2, Surya P Bhatt3,2,4, Wassim W Labaki5, Farbod N Rahaghi6, Matthew Moll6,7, Russ P Bowler8, Elizabeth A Regan9, Barry J Make8, James D Crapo8, Raul San Jose Estepar10, Alejandro A Diaz6, Edwin K Silverman6,7, MeiLan K Han5, Brian Hobbs6,7, Michael H Cho6, George R Washko6, Mark T Dransfield3,2,11, J Michael Wells3,2,11.   

Abstract

Entities:  

Year:  2020        PMID： 31772001      PMCID： PMC7179358          DOI： 10.1183/13993003.01812-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  17 in total

1.  Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.

Authors:  J Michael Wells; Anand S Iyer; Farbod N Rahaghi; Surya P Bhatt; Himanshu Gupta; Thomas S Denney; Steven G Lloyd; Louis J Dell'Italia; Hrudaya Nath; Raul San Jose Estepar; George R Washko; Mark T Dransfield
Journal:  Circ Cardiovasc Imaging       Date:  2015-04       Impact factor: 7.792

2.  Genetic epidemiology of COPD (COPDGene) study design.

Authors:  Elizabeth A Regan; John E Hokanson; James R Murphy; Barry Make; David A Lynch; Terri H Beaty; Douglas Curran-Everett; Edwin K Silverman; James D Crapo
Journal:  COPD       Date:  2010-02       Impact factor: 2.409

3.  Mortality risk as a function of the ratio of pulmonary trunk to ascending aorta diameter in patients with suspected coronary artery disease.

Authors:  Rine Nakanishi; Jamal S Rana; Aryeh Shalev; Heidi Gransar; Sean W Hayes; Troy M Labounty; Damini Dey; Romalisa Miranda-Peats; Louise E J Thomson; John D Friedman; Aiden Abidov; James K Min; Daniel S Berman
Journal:  Am J Cardiol       Date:  2013-02-14       Impact factor: 2.778

4.  Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study.

Authors:  Jeffrey I Stewart; Sarah Moyle; Gerard J Criner; Carla Wilson; Ron Tanner; Russell P Bowler; James D Crapo; Robert K Zeldin; Barry J Make; Elizabeth A Regan
Journal:  COPD       Date:  2012-06-07       Impact factor: 2.409

5.  Predictors of rehospitalization and death after a severe exacerbation of COPD.

Authors:  Ryan McGhan; Tiffany Radcliff; Ron Fish; E Rand Sutherland; Carolyn Welsh; Barry Make
Journal:  Chest       Date:  2007-09-21       Impact factor: 9.410

6.  Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.

Authors:  E Weitzenblum; C Hirth; A Ducolone; R Mirhom; J Rasaholinjanahary; M Ehrhart
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

7.  Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.

Authors:  J Michael Wells; Joshua B Morrison; Surya P Bhatt; Hrudaya Nath; Mark T Dransfield
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

8.  Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Authors:  Stephanie Shin; Christopher S King; A Whitney Brown; Maria C Albano; Melany Atkins; Michael J Sheridan; Shahzad Ahmad; Kelly M Newton; Nargues Weir; Oksana A Shlobin; Steven D Nathan
Journal:  Respir Med       Date:  2014-09-02       Impact factor: 3.415

9.  COPD/emphysema: The vascular story.

Authors:  Norbert F Voelkel; Jose Gomez-Arroyo; Shiro Mizuno
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

10.  IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.

Authors:  Jin Hwa Lee; Michael H Cho; Craig P Hersh; Merry-Lynn N McDonald; J Michael Wells; Mark T Dransfield; Russell P Bowler; David A Lynch; David A Lomas; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2015-03       Impact factor: 6.914
View more
  7 in total

1.  Machine Learning and Prediction of All-Cause Mortality in COPD.

Authors:  Matthew Moll; Dandi Qiao; Elizabeth A Regan; Gary M Hunninghake; Barry J Make; Ruth Tal-Singer; Michael J McGeachie; Peter J Castaldi; Raul San Jose Estepar; George R Washko; James M Wells; David LaFon; Matthew Strand; Russell P Bowler; MeiLan K Han; Jorgen Vestbo; Bartolome Celli; Peter Calverley; James Crapo; Edwin K Silverman; Brian D Hobbs; Michael H Cho
Journal:  Chest       Date:  2020-04-27       Impact factor: 9.410

2.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

3.  Functional imaging of COPD by CT and MRI.

Authors:  David A Lynch
Journal:  Br J Radiol       Date:  2021-09-19       Impact factor: 3.629

4.  Pulmonary Artery Enlargement Is Associated with Exacerbations and Mortality in Ever-Smokers with Preserved Ratio Impaired Spirometry.

Authors:  R Chad Wade; J Patrick Simmons; Adel Boueiz; Andrew Gregory; Emily S Wan; Elizabeth A Regan; Surya P Bhatt; MeiLan K Han; Russell P Bowler; James D Crapo; Edwin K Silverman; George R Washko; Mark T Dransfield; J Michael Wells
Journal:  Am J Respir Crit Care Med       Date:  2021-08-15       Impact factor: 30.528

5.  Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.

Authors:  Carrie L Pistenmaa; P Nardelli; S Y Ash; C E Come; A A Diaz; F N Rahaghi; R G Barr; K A Young; G L Kinney; J P Simmons; R C Wade; J M Wells; J E Hokanson; G R Washko; R San José Estépar
Journal:  Chest       Date:  2021-02-16       Impact factor: 10.262

Review 6.  Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?

Authors:  Jennifer M Wang; MeiLan K Han; Wassim W Labaki
Journal:  Curr Opin Pulm Med       Date:  2022-03-01       Impact factor: 3.155

7.  Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort.

Authors:  Ana Ezponda; Ciro Casanova; Miguel Divo; Marta Marín-Oto; Carlos Cabrera; Jose M Marín; Gorka Bastarrika; Víctor Pinto-Plata; Ángela Martin-Palmero; Francesca Polverino; Bartolome R Celli; Juan P de Torres
Journal:  Respirology       Date:  2022-02-07       Impact factor: 6.175
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.